DJIA 18,080.14 21.45 0.12%
NASDAQ 5,092.09 36.02 0.71%
S&P 500 2,117.69 4.76 0.23%
market minute promo

Sanofi (ADR) (NYSE: SNY)

51.75 -0.01 (-0.02%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

SNY $51.75 -0.02%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $51.62
Previous Close $51.76
Daily Range $51.28 - $52.10
52-Week Range $43.57 - $57.42
Market Cap $136.6B
P/E Ratio 27.83
Dividend (Yield) $1.62 (2.1%)
Ex-Dividend Date
Dividend Pay Date
05/06/15
06/02/15
Volume 774,861
Average Daily Volume 1,506,532
Current FY EPS $3.01

Sector

Healthcare

Industry

Drug Makers

Sanofi (ADR) (SNY) Description

A global pharmaceutical group engaged in the research, development, manufacture and marketing of healthcare products. Website: http://www.sanofi.com/

News & Commentary

Mixed Bag for ImmunoGen Inc.

Pipeline progressing but with some setbacks mixed in.

Dodge & Cox Stock Fund First Quarter 2015 Commentary

Illumina's Earnings Set Positive Tone for Biotech

What's behind Illumina's remarkable earnings beat, and what could it mean for biotech stocks?

10 Most Hated Companies in Healthcare

When emotional trading is on display, the short-sellers come out to play. Find out which companies are the most hated in healthcare, why they're so universally disliked, and which company may eventually deserve a reprieve.

Alnylam Reports Positive Patisiran Results, Shares Up - Analyst Blog

Why Alnylam Pharmaceuticals, Inc. Shares Are Soaring Today

Alnylam Pharmaceuticals, Inc. has reported positive phase 2 results for patisiran.

Genzyme Initiates Phase 2a Clinical Trial to Evaluate Oral Therapy for Fabry Disease

The 3 Best Stocks for Investing in Cholesterol Drugs

An aging population and rising prevalence of heart disease suggest that investing in the next generation of cholesterol drugs could prove to be profitable.

Actelion to Boost Progress of Specialty Immunology Pipeline - Analyst Blog

3 Potential Blockbuster Drugs That Could Be Approved Before Year's End

Our experts weigh in on some drug candidates with huge potential.

See More SNY News...

SNY's Top Competitors

SNY $51.75 (-0.02%)
Current stock: SNY
JNJ $101.08 (0.62%)
Current stock: JNJ
GSK $46.59 (0.60%)
Current stock: GSK
AZN $71.79 (-1.83%)
Current stock: AZN